Who founded RoosterBio?

RoosterBio was founded by Jon Rowley in 2012.

Who are RoosterBio's investors?

RoosterBio's investors include Dynamk Capital, Maryland TEDCO, TEDCO, Vanedge Capital, Vanedge Capital Limited Partnership, Avant Bio.

How much funding has RoosterBio raised?

RoosterBio has disclosed $33.5M raised across 5 of its 6 known rounds.

Where is RoosterBio headquartered?

RoosterBio is headquartered in Frederick, US.

RoosterBio

Frederick, US · Founded 2012 · Delaware corporation · 6 known investors

Find your way into RoosterBio

283 people in our graph share verified history with the RoosterBio team — schools, employers, funds. One of them is your warm intro.

Chas Pulidounlockedknows Jon Rowley · together at ▶︎ STRM.BIO (overlapped)

×2knows the team · via RoosterBio Inc.

knows the team · via Aastrom Biosciences

×5knows the team · via Biolifesolutions

×3knows the team · via Lonza

A stem cell tools and technology company providing standardized platforms to accelerate regenerative medicine development and clinical trials.

Biotech

Founders & leadership

RoosterBio was founded in 2012 by Jon Rowley.

Jon Rowley FounderJon Rowley founded RoosterBio in 2013 to develop standardized platforms for incorporating human mesenchymal stem cells into regenerative medicine and advanced therapy development. He brings expertise in commercial translation of cellular technologies and therapeutic cell manufacturing process development, and serves as a board director and startup advisor at the Frederick Innovative Technology Center.

Timothy KellyExecutive

Margot ConnorExecutive

Uplaksh KumarChief Operating Officer

Board

Martin WestbergBoard director

Rob CarlsonBoard director

Daniella Kranjac Board directorInvestor at Avant Bio

Robert PretiBoard director

Investors · 6

Dynamk Capitallisted by Dynamk CapitalNew York

How we know: a partner's Signal profile · funding news · dynamk.vc · Not right? Tell us

Maryland TEDCOlisted by Maryland TEDCOColumbia · $500K – $1.5M

How we know: Maryland TEDCO's portfolio page · Not right? Tell us

TEDCOlisted by TEDCOColumbia

Vanedge Capitallisted by Vanedge CapitalVancouver · $1M – $15M

How we know: Vanedge Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Vanedge Capital Limited Partnershiplisted by Vanedge Capital Limited PartnershipVancouver

How we know: Vanedge Capital Limited Partnership's portfolio page · Not right? Tell us

Avant BioinferredNew Yorkvia Daniella Kranjac · board

How we know: board seat on SEC Form D · Not right? Tell us

Funding

SEC filings, press & company announcements

$33.5M disclosed across 5 of 6 rounds · 2013–2024

Undisclosed amountSeries BSep 2019
Source ↗
$15MSeries BAug 2019 · 3 sources
Dynamk Capital (lead)
Source ↗

▶$12MraisedJul 2024 · 8 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Jon RowleyDirector
Martin WestbergDirector
Robert PretiDirector
Rob CarlsonDirector
Daniella KranjacDirector
Timothy KellyExecutive Officer, Director

Offering amount: $12M
Amount sold: $12M
First sale: Mar 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.2MraisedFeb 2017 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jon A. RowleyExecutive Officer, Director
Robert CarlsonDirector
Margot ConnorExecutive Officer, Director

Offering amount: $5.2M
Amount sold: $5.2M
First sale: Nov 2016
Incorporated: Corporation, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.3MraisedFeb 2017 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jon RowleyExecutive Officer, Director
Margot ConnorExecutive Officer, Director
Robert CarlsonDirector

Offering amount: $1.3M
Amount sold: $1.3M
First sale: Jan 2017
Incorporated: Corporation, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$100KraisedJan 2014 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Uplaksh KumarExecutive Officer, Director
Jon RowleyExecutive Officer, Director

Offering amount: $1M
Amount sold: $100K
Minimum investment: $20K
Proceeds to insiders: $60K
First sale: Dec 2013
Incorporated: Corporation, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Oup32 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

Companies competing with RoosterBio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does RoosterBio do?: A stem cell tools and technology company providing standardized platforms to accelerate regenerative medicine development and clinical trials.
Who founded RoosterBio?: RoosterBio was founded by Jon Rowley in 2012.
Who are RoosterBio's investors?: RoosterBio's investors include Dynamk Capital, Maryland TEDCO, TEDCO, Vanedge Capital, Vanedge Capital Limited Partnership, Avant Bio.
How much funding has RoosterBio raised?: RoosterBio has disclosed $33.5M raised across 5 of its 6 known rounds.
Where is RoosterBio headquartered?: RoosterBio is headquartered in Frederick, US.